Toggle navigation
About Us
Portfolio
News
Contact Us
Lightchain Capital
Recent News
May 26, 2021
C4 Therapeutics to Advance CFT8919, A Selective Degrader of EGFR L858R, Into IND-enabling Studies
READ MORE
May 25, 2021
Geneoscopy Announces Publication of Peer-Reviewed Article Highlighting Effective Noninvasive Screening Test for Colorectal Cancer Prevention
READ MORE
May 20, 2021
C4 Therapeutics Appoints Lauren White as Chief Financial Officer
READ MORE
May 17, 2021
Wugen: deploying memory NK cells against cancer
READ MORE
May 13, 2021
C4 Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results
READ MORE
May 12, 2021
C4 Therapeutics to Present at Upcoming Investor Conferences
READ MORE
May 07, 2021
Revenue share program launched by hospital network
READ MORE
May 07, 2021
CareVet announces new revenue bonus program for all veterinary team members
READ MORE
May 03, 2021
CareVet Launches Monthly Revenue Share Program
READ MORE
1
20
21
22
23
24
25
26
...
29
Contact Us
Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131
You need to fill the captcha in order to continue
Submit
4837,4748,4815,4823,4811,4819,4822,4748,4772,4748,4820,4823,4813,4813,4822,4811,4828,4835,4778,4822,4819,4817,4818,4830,4813,4818,4811,4819,4824,4759,4813,4811,4826,4819,4830,4811,4822,4760,4813,4825,4823,4748,4758,4748,4829,4831,4812,4820,4815,4813,4830,4748,4772,4748,4781,4825,4824,4830,4811,4813,4830,4746,4784,4825,4828,4823,4748,4839
©2025 LIGHTCHAIN CAPITAL, LLC All Rights Reserved |
Privacy Policy
Website by
Tidal Media Group
